drugset / Trial / NCT05522816
KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a Phase I dose escalation study to assess the safety, tolerability and activity of three different strengths of topical KX01 in the treatment of patients with plaque-type psoriasis.
Timeline
- Start
- 2015-10-27
- Primary completion
- 2021-03-10
- Completion
- 2021-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirbanibulin | Small molecule | 0.01 % | Topical |
| Subject | Tirbanibulin | Small molecule | 0.1 % | Topical |
| Subject | Tirbanibulin | Small molecule | 1 % | Topical |